跳至主要内容
临床试验/CTRI/2020/04/024548
CTRI/2020/04/024548尚未招募未知

A COMPARATIVE STUDY OF SAFETY AND EFFICACY OF ORAL IRON THERAPY VERSUS INTRAVENOUS IRON SUCROSE VERSUS INTRAVENOUS FERRIC CARBOXYMALTOSE IN THE TREATMENT OF IRON DEFICIENCY ANAEMIA IN THE TREATMENT OF IRON DEFICIENCY ANEMIA DURING PREGNANCY

Dr Shreedevi Kori0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • a.All the antenatal women with 16 to 34 weeks period of gestation.
  • b.All the antenatal women who are diagnosed with iron deficiency anemia
  • with HB 7-10.9gm%
  • c.All the antenatal women with singleton pregnancy.

排除标准

  • 1.Any Blood transfusion or have undergone iron theray within 3 months.
  • 2.Anaemia not caused by iron deficiency.
  • 3.Evidence of any significant abnormalities on anomaly ultrasound.
  • 4.Known hypersensitivity to FCM or other IV iron preparations.
  • 5.History of fever or chronic illness like malaria, dengue, diarrhea , dysentery and piles.
  • 6.Not consenting

研究者

发起方
Dr Shreedevi Kori

相似试验

To compare different iron therapy for anemic... | 临床试验